Document is current
Any future updates will be listed below
-
Authors
Domingos, Vera https://orcid.org/0000-0003-1733-5221
Nezvalova-Henriksen, Katerina
Dadkhah, Adrin https://orcid.org/0000-0002-3301-0059
Moreno-Martinez, Maria-Estela https://orcid.org/0000-0001-6752-873X
Ben Hassine, Khalil
Pires, Vera
Kröger, Nicolaus
Bauters, Tiene
Hassan, Moustapha https://orcid.org/0000-0003-1927-5859
Duncan, Nick https://orcid.org/0000-0002-1191-8170
Kalwak, Krzysztof
Ansari, Marc
Langebrake, Claudia
Admiraal, Rick https://orcid.org/0000-0003-1512-2791
- License Information
-
More Information
Article History
Received: 18 March 2024
Revised: 1 August 2024
Accepted: 4 September 2024
First Online: 13 September 2024
Competing interests
: MEMM declares honoraria as a speaker, consultancy or advisory role from Daiichy Sankio España, GSK, Gilead, Incyte, Seagen, Servier, all not related to the current topic. ND declares honoraria as a speaker from Novartis and Gilead, and travel grants from Novartis. KK declares honoraria as a speaker from Medac, Novartis, Pierre Fabre and travel grants from Pierre-Fabre, all not related to the current topic. RA declares an unrestricted research grant from Sanofi, not related to the current topic. VD, KNH, AD, KBH, VP, NK, TB, MH, MA and CL declare no conflicts of interest.
